Ads
related to: congestive heart failure from chemotherapy
Search results
Results from the WOW.Com Content Network
The most dangerous side effect of doxorubicin is dilated cardiomyopathy, leading to congestive heart failure. The rate of cardiomyopathy is dependent on its cumulative dose, with an incidence about 4% when the dose of doxorubicin is 500–550 mg/m 2, 18% when the dose is 551–600 mg/m 2 and 36% when the dose exceeds 600 mg/m 2. [19]
As an example, the incidence of congestive heart failure is 4.7%, 26% and 48% respectively when patients received doxorubicin at 400 mg/m 2, 550 mg/m 2 and 700 mg/m 2. [4] Therefore, the lifetime cumulative doxorubicin exposure is limited to 400–450 mg/m 2 in order to reduce congestive heart failure incidence to less than 5%, although ...
Chemotherapy can treat amyloidosis if it is related to immunoglobulins. [4] Liver transplant can treat amyloidosis if it is related to familial transthyretin. [4]Acoramidis (Attruby) was approved for medical use in the United States in November 2024, to treat adults with cardiomyopathy of wild-type or variant (hereditary) transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and ...
The treatment, which goes beyond standard chemotherapy, uses multiple medications to target a specific mutation of the cancer. ... He says he was hypoxic, had congestive heart failure and had a ...
Heart failure (HF), also known as congestive heart failure (CHF), is a syndrome caused by an impairment in the heart's ability to fill with and pump blood.. Although symptoms vary based on which side of the heart is affected, HF typically presents with shortness of breath, excessive fatigue, and bilateral leg swelling. [3]
It was a difficult year during which Jim, 83, faced multiple serious health issues, including congestive heart failure, an acute kidney injury and bladder cancer.
Ads
related to: congestive heart failure from chemotherapy